Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
📧 Sign up to get email alerts when something new happens for Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS approval · 2026-03-05Clinical Trial Update: Single Patient Expanded Access Treatment Plan For The Investigational Product Narsoplimab
Narsoplimab has been approved for marketing for hematopoietic stem cell transplant-associated thrombotic microangiopathy, and the document n…